To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
Opioid Addiction Prevention Act of 2017
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to comply with certain requirements when prescribing opioids for the initial treatment of acute pain, such as a limit on the initial supply.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the requirements.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Read twice and referred to the Committee on the Judiciary.
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line